WELCOME TO The PHARMACEUTICAL REPORT
Home > Events >
Past Conferences >
B2B Sales & Marketing Exchange
August 12-13, 2019 | USA
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company has announced its subsidiary, Algernon NeuroScience has dosed the first subject in the Phase 1 DMT clinical stroke study.
January 17-18, 2023 | UK
November 27-30, 2022 | Germany
December 6-7, 2022 | USA
January 30-31, 2023 | Spain
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE